...
首页> 外文期刊>BMC Medical Informatics and Decision Making >Impact of electronic medication reconciliation interventions on medication discrepancies at hospital transitions: a systematic review and meta-analysis
【24h】

Impact of electronic medication reconciliation interventions on medication discrepancies at hospital transitions: a systematic review and meta-analysis

机译:电子药物和解干预措施对医院过渡期药物差异的影响:系统评价和荟萃分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Medication reconciliation has been identified as an important intervention to minimize the incidence of unintentional medication discrepancies at transitions in care. However, there is a lack of evidence for the impact of information technology on the rate and incidence of medication discrepancies identified during care transitions. This systematic review was thus, aimed to evaluate the impact of electronic medication reconciliation interventions on the occurrence of medication discrepancies at hospital transitions. Methods Systematic literature searches were performed in MEDLINE, PubMed, CINHAL, and EMBASE from inception to November, 2015. We included published studies in English that evaluated the effect of information technology on the incidence and rate of medication discrepancies compared with usual care. Cochrane’s tools were used for assessment of the quality of included studies. We performed meta-analyses using random-effects models. Results Ten studies met our inclusion criteria; of which only one was a randomized controlled trial. Interventions were carried out at various hospital transitions (admission, 5; discharge, 2 and multiple transitions, 3 studies). Meta-analysis showed a significant reduction of 45?% in the proportion of medications with unintentional discrepancies after the use of electronic medication reconciliation (RR 0.55; 95?% CI 0.51 to 0.58). However, there was no significant reduction in either the proportion of patients with medication discrepancies or the mean number of discrepancies per patient. Drug omissions were the most common types of unintended discrepancies, and with an electronic tool a significant but heterogeneously distributed reduction of omission errors over the total number of medications reconciled have been observed (RR 0.20; 95?% CI 0.06 to 0.66). The clinical impact of unintended discrepancies was evaluated in five studies, and there was no potentially fatal error identified and most errors were minor in severity. Conclusion Medication reconciliation supported by an electronic tool was able to minimize the incidence of medications with unintended discrepancy, mainly drug omissions. But, this did not consistently reduce other process outcomes, although there was a lack of rigorous design to conform these results.
机译:背景技术药物和解已被认为是一项重要的干预措施,可最大程度地减少护理过渡期间意外药物差异的发生。但是,缺乏证据表明信息技术对护理过渡期间发现的药物差异的发生率和发生率有影响。因此,本系统综述旨在评估电子药物和解干预措施对医院过渡期间药物差异发生的影响。方法从开始到2015年11月,在MEDLINE,PubMed,CINHAL和EMBASE中进行系统的文献检索。我们纳入了英文出版的研究,评估了信息技术与常规护理相比对药物差异发生率和发生率的影响。 Cochrane的工具用于评估纳入研究的质量。我们使用随机效应模型进行了荟萃分析。结果十项研究符合我们的纳入标准。其中只有一项是随机对照试验。在不同的医院过渡期进行了干预(入院,5;出院,2和多次过渡,3研究)。荟萃分析显示,使用电子药物对账后,无意间出现差异的药物比例显着降低了45%(RR 0.55; 95%CI 0.51至0.58)。但是,有药物差异的患者比例或每位患者的平均差异数量均没有显着降低。药物遗漏是最常见的意外差异,并且使用电子工具可以观察到在所调和的药物总数上,遗漏误差显着但异类分布的减少(RR 0.20; 95%CI 0.06至0.66)。在五项研究中评估了意想不到的差异的临床影响,并且没有发现潜在的致命错误,而且大多数错误的严重性都较小。结论电子工具支持的药物核对能够最大程度地减少意外差异(主要是药物遗漏)的药物发生率。但是,尽管缺乏严格的设计来符合这些结果,但这并不能持续降低其他过程的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号